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Abstract
Whether patients whose catheter tip grows Staphylococcus aureus but who have no concomitant bacteraemia should receive antimicrobials
remains an unresolved issue. However, a proportion of patients with catheter tips colonized by S. aureus have no blood cultures taken
because of low suspicion of sepsis and the meaning of this microbiological ﬁnding is unknown. We have analysed all catheter tips grow-
ing S. aureus during a 6-year period and have selected patients without blood cultures taken 7 days before or after central vascular cath-
eter removal. Patient’s evolution was classiﬁed into good and poor outcome. Poor outcome was deﬁned as S. aureus infection within
3 months after catheter withdrawal or death in the same period with no obvious cause. Patients with good and poor outcomes were
compared to assess whether antimicrobial therapy inﬂuenced evolution. Sixty-seven patients fulﬁlled our inclusion criteria and ﬁve
(7.4%) had a poor outcome. The administration of early anti-staphylococcal therapy had no impact on the outcome of this population
(p 0.99). The only factor independently associated with a poor outcome was the presence of clinical signs of sepsis when the catheter
was removed (OR 20.8; 95% CI 2.0–206.1; p 0.009). Our data suggest that patients with central vascular catheter tips colonized with
S. aureus should be closely monitored for signs and symptoms of ongoing infection, but if these are not present then antimicrobial ther-
apy does not seem justiﬁed.
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Introduction
The clinical signiﬁcance of endovascular catheter tip coloniza-
tion in patients without bacteraemia/fungaemia is an unre-
solved issue in the guidelines of the Infectious Diseases
Society of America/European Society for Clinical Microbiol-
ogy and Infectious Diseases. These guidelines actually state
that tip colonization does not require therapy in most cases
[1]. However, Staphylococcus aureus and Candida tip coloniza-
tion purportedly confer a higher risk than other microorgan-
isms of causing catheter-related bloodstream infection. Our
group reported that in an unselected population of patients
with catheter tips colonized by Candida and no candidaemia
(within a week of catheter removal), antifungal therapy did
not inﬂuence outcome [2].
In contrast, data from selected septic patients admitted to
an intensive-care unit with catheter tips colonized by
S. aureus and with negative blood cultures at catheter arrival
in the microbiology department, suggest that bacteraemia
may occur within the next week in 12–15% of individuals.
Under those circumstances, antimicrobial therapy within
24 h of removal of the catheter may reduce the risk of sub-
sequent S. aureus bacteraemia and other septic complications
[3,4]. Accordingly, guidelines recommend a 5- to 7-day
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course of antibiotics in all those patients and close monitor-
ing for signs and symptoms of ongoing infection [1].
In our opinion, the recommendation to treat critical
patients who have sepsis and whose catheters are colonized
with S. aureus cannot be generalized to other populations in
less severe condition. We assume that patients with catheter
tips colonized with S. aureus in which blood cultures were
not even obtained are a population with a low suspicion of
sepsis [5]. To clarify this issue, we analysed the inﬂuence of
anti-staphylococcal therapy on the outcome of adult patients
with S. aureus-colonized vascular catheters withdrawn in
whom no blood cultures were requested within 7 days of
catheter removal.
Patients and Methods
Setting
Our institution is a 1750-bed tertiary teaching hospital with
all medical and surgical specialties serving a population of
c. 715 000 inhabitants. The Microbiology Department pro-
cesses all catheter tips sent for culture from both intensive-
care and non-intensive-care unit patients.
Design
Retrospective analysis was performed of all adult patients
with S. aureus cultured from intravascular catheter tips dur-
ing the period 1 March 2003 to 1 June 2008 and for whom
no blood cultures were requested of the microbiology labo-
ratory in the 7 days before and 7 days after intravenous
catheter removal. Patients with simultaneous S. aureus infec-
tion at other sites were excluded.
Patients were classiﬁed depending on the clinical outcome
in two groups: good and poor outcome. Patients who devel-
oped an S. aureus infection within the 3-month follow-up
period or who died within the current admission with no
other obvious cause were considered to have a poor out-
come. Those not fulﬁlling these criteria were considered to
have a good outcome. The two groups were compared to
identify poor prognostic factors and to assess the inﬂuence
of anti-staphylococcal therapy on the outcome.
Deﬁnitions
Staphylococcus aureus colonization of the catheter tip was
deﬁned as the presence of ‡15 CFUs on the semi-quantita-
tive culture of the intravascular catheter tip. Bacteraemia
was deﬁned as the presence of S. aureus in one or more
blood cultures obtained from peripheral veins.
Clinical data were retrieved from the patient’s chart and
follow up was recorded from the day of intravenous catheter
removal until discharge. To identify late complications, pro-
gress at 3 months was checked in all survivors.
A pre-established protocol was developed to recover clin-
ical and microbiological data. Analysed variables included
patient characteristics, underlying diseases, Charlson’s co-
morbidity score, and the maximum sepsis severity reached
when the central venous catheter was removed [6]. Micro-
biological data from the central venous catheter and blood
cultures were also recorded.
All antimicrobial therapy with anti-staphylococcal activity
was recorded. Anti-staphylococcal therapy was considered
adequate when an oral or parenteral antimicrobial agent with
in vitro activity against the S. aureus isolated from the patient
was administered (within the period from 7 days before to
7 days after central venous catheter removal).
Laboratory procedures
Catheter tips were processed using the semi-quantitative cul-
ture method. Blood cultures were processed according to
routine methods using the semi-automatic culture detector
(Bactec 9240, Bactec Plus Aerobic/F; Becton Dickinson
Microbiology Systems, Sparks, MD, USA). The microorgan-
isms recovered were fully identiﬁed by standard microbiolog-
ical methods.
Statistical analysis
Continuous variables were compared using the Student’s
t-test for normally distributed variables. Categorical variables
were evaluated using the chi-square test or two-tailed Fisher
exact test. Values are expressed as the mean (SD) or median
(interquartile range) for continuous variables and as percent-
ages, with a 95% CI for categorical variables.
Two-tailed tests of signiﬁcance at a p value of <0.05 were
used to determine statistical signiﬁcance. Backward stepwise
multivariate analysis was performed to identify independent
prognostic factors for outcome. For this analysis, we used
binary logistic regression and incorporated variables found to
be signiﬁcant and those with a p value £0.1 in the univariate
comparison. Statistical analysis was performed using the pro-
gram SPSS (SPSS, Inc., 13.0, Chicago, IL, USA).
Results
During the study period, 380 adult patients had a central
venous catheter tip colonized by S. aureus at our institution.
According to our study design, the following cases were not
included: 294 patients from whom blood cultures were
requested (167, or 56.8%, had S. aureus bloodstream infec-
tion), eight patients with incomplete clinical data and 11
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patients with simultaneous non-bacteraemic S. aureus infec-
tion. Accordingly, our study population comprised 67
patients with S. aureus in a central venous catheter tip and
with no suspicion of bacteraemia (no blood cultures
obtained).
Overall, forty-ﬁve patients (67.1%) were men and the
mean (SD) age was 64.8 (18.7) years. Tables 1 and 2 summa-
rize the characteristics of the 67 patients and the 67 cathe-
ters according to their outcome—62 (92.5%) with good
outcome and ﬁve (7.5%) with poor outcome. The poor out-
come group included three patients who died shortly after
catheter removal. Only one of them had proven S. aureus
infection (bloodstream infection 8 days after the catheter
was removed). According to their clinical records, these
patients should have had blood cultures obtained because
they were febrile when the catheter was withdrawn and had
local signs of infection at the catheter entry site. The remain-
ing two patients of the poor outcome group survived but
developed late S. aureus-related complications 51 and 80 days
after catheter withdrawal, which cannot be unequivocally
related to the catheter colonization—namely, a subphrenic
abscess after severe pancreatitis and osteomyelitis in a poly-
trauma patient (Table 3).
Epidemiological characteristics and underlying conditions
were similar in both groups, with the exception of a higher
proportion of patients with chronic obstructive pulmonary
disease in the poor outcome group, a clinical situation of
greater severity when the catheter was withdrawn, and more
invasive procedures, usually attributable to their underlying
conditions (pancreatitis, abdominal sepsis, etc.)
The proportion of patients receiving any antimicrobial
agent or receiving effective anti-staphylococcal drugs and the
duration of therapy was similar in patients with poor and
good outcomes (Table 1). After our retrospective review of
medical records, we considered that 14 of the patients could
have had manifestations compatible with sepsis at catheter
withdrawal. However, most of them had other explanations
for these ﬁndings—i.e. other known source of infection,
recent surgery—so the clinical signs were not considered to
be related to potential catheter infection by the attending
physician, and no blood cultures were ordered at that time.
In fact, only one of these patients—previously men-
tioned—developed subsequent S. aureus bacteraemia.
Characteristics of the catheters
Placement of involved lines was: 19 jugular, 15 subclavian,
nine femoral, six upper limb and one lower limb; in 17
patients the insertion site could not be determined. The
median duration of catheter in situ was 9 days (interquartile
range: 5–15). The main characteristics of the involved
TABLE 1. Characteristics of the patients fulﬁlling inclusion criteria divided in two groups: poor and good outcome
Characteristic
Overall
(n = 67)
Poor outcome
(n = 5)
Good outcome
(n = 62) p
Mean age in years 64.57 ± 18.75 57.8 ± 24.8 654.1 ± 18.3 0.5
Male sex 45 (67.16) 5 (100) 40 (64.5) 0.1
McCabe stage
Non fatal 54 (80.5) 4 (80) 50 (80.6) 1
Ultimately fatal 13 (19.4) 1 (20) 12 (19.4) 1
Rapidly fatal 0 0 0 –
Mean Charlson index 3.7 ± 2.89 3.6 ± 3.5 3.7 ± 2.8 0.9
Underlying conditions
Surgery 49 (73.13) 4 (80) 45 (72.6) 1
Other invasive procedures 24 (35.82) 5 (100) 19 (30.6) 0.004
Neoplasia 33 (49.25) 3 (60) 30 (48.4) 0.7
Diabetes mellitus 18 (26.8) 1 (20) 17 (27) 1
Prosthetic material 18 (26.86) 3 (60) 15 (24) 0.1
Corticosteroid therapy 15 (22.38) 0 (0) 15 (24) 0.6
Other immunosuppressors 4 (5.97) 0 (0) 4 (6.5) 1
IVDA 1 (1.49) 0 (0) 1 (1.6) 1
COPD 13 (19.4) 3 (60) 10 (16) 0.04
Haemodialysis 3 (4.47) 0 3 (5) 1
Clinical signs of sepsisa 14 (20.9%) 4 (80) 10 (16) 0.01
Antimicrobial therapy
Any antimicrobial drug 29 (43) 2 (40) 27 (43) 1
Effective treatment for S. aureus 14 (21) 1 (20) 13 (21) 1
Days of effective treatment 6 ± 2.5 5 ± 0 6.5 ± 2.6 0.7
Death
Not related to S. aureus 26 (39) 2 (40) 24 (39) 1
S. aureus-related death 1 (1.5) 1 (20) 0
aAccording to the authors’ opinion.
COPD, chronic obstructive pulmonary disease; IVDA, intravenous drug abuse; S. aureus, Staphylococcus aureus.
Boldface p-values indicate signiﬁcant difference between poor and good outcome.
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catheters are summarized in Table 2. We were not able to
ﬁnd any signiﬁcant differences between the two groups of
patients (improvement or poor outcome) in terms of cathe-
ter use, type, insertion site and indwelling time. There was a
trend towards a higher rate of signs of infection at the inser-
tion site in patients with a poor outcome, but the difference
was not statistically signiﬁcant.
Microbiological ﬁndings
Methicillin-resistant S. aureus (MRSA) accounted for 67% of
the isolates. Patients with MRSA and methicillin-sensitive
S. aureus (MSSA) tip colonization are compared in Table 4.
Diabetes mellitus and a lower rate of effective treatment
(both before catheter removal and at catheter removal)
were signiﬁcantly more common in patients with MRSA col-
onization than in patients with MSSA catheter colonization.
Analysis of prognostic factors for a poor outcome
Poor prognostic factors identiﬁed in the univariate analysis
were chronic obstructive pulmonary disease (p 0.04), inva-
sive procedures (p 0.004) and clinical signs of sepsis (p 0.01).
In the multivariate analysis, the only independent factor asso-
ciated with a poor outcome in patients with S. aureus tip col-
onization and no blood cultures taken was clinical signs
compatible with sepsis when the catheter was removed (OR
TABLE 2. Characteristics of the catheters comparing pa-
tients with good and poor outcomes
Characteristic
Global
(n = 67)
Poor
outcome
(n = 5)
Good
outcome
(n = 62) p
Purpose of intravenous
catheter
Haemodialysis 4 (6.0) 0 (0) 4 (6.5) 0.9
Inotropic drug 3 (4.5) 0 (0) 3 (4.8)
Total parenteral
nutrition
8 (11) 1 (20) 7 (11.3)
Chemotherapy 3 (4.5) 0 (0) 3 (4.8)
Several uses 49 (73.1) 4 (80) 45 (72.6)
Insertion site
Femoral 9 (13.4) 0 (0) 9 (15.1) 0.8
Lower limbs 1 (1.5) 0 (0) 1 (1.6)
Upper limbs 6 (9) 0 (0) 6 (9.7)
Subclavian 15 (22.4) 1 (20) 14 (22.6)
Jugular 19 (28.4) 2 (40) 17 (27.4)
Unknown 17 (25.4) 2 (40) 15 (24.2)
Catheter type
Arterial 2 (2.98) 0 (0) 2 (3.2) 1
Haemodialysis 1 (1.5) 0 (0) 1 (1.6)
Peripheral 2 (3) 0 (0) 2 (3.2)
Central 60 (89.6) 5 (100) 55 (89)
Peripherally inserted
central line
1 (1.5) 0 (0) 1 (1.6)
Swanz–Ganz 1 (1.5) 0 (0) 1 (1.6)
Removal cause
End of use 36 (53.7) 3 (60) 33 (53.2) 0.9
Suspicion of infection 23 (34.3) 2 (40) 21 (34)
Dysfunction 2 (3) 0 (0) 2 (3.2)
Replacement protocol 1 (1.5) 0 (0) 1 (1.6)
Unknown 5 (7.5) 0 (0) 5 (8.1)
Duration of catheter in situ 12.3 ± 10.9 12.2 ± 11.1 12.3 ± 11.0 0.9
TABLE 3. Characteristics of the three patients who developed Staphylococcus aureus complications
Underlying
condition
Colonization
of catheter tip
Catheter
in situ (days)
Effective
therapy (days)
Infectious
complication
Day after catheter
withdrawal
Diabetes, COPD,
coronariography
MRSA 8 0 Bacteraemia +8
Severe pancreatitis MRSA 25 0 Subphrenic abscess +51
Polytrauma MSSA 5 7 Osteomyelitis +80
COPD, chronic obstructive pulmonary disease; MRSA, methicillin-resistant S. aureus; MRSA, methicillin-sensitive S. aureus.
TABLE 4. Comparison of patients with MRSA and MSSA catheter colonization
Global MSSA
(n = 22)
MRSA
(n = 45)
p
Mean age (years) 64.8 60.59 66.51 0.23
Male sex 45 (67.2) 17 (77.3) 28 (62.2) 0.27
Mean Charlson’s index 3 (4.5) 6.38 ± 3.54 4.07 ± 2.9 0.14
Diabetes mellitus 14 (20.9) 5 (55.6) 9 (15.5) 0.01
Haemodialysis 16 (23.9) 2 (9.1) 1 (2.2) 0.25
Catheter exit site infection 14 (20.9) 8 (36.4) 8 (17.8) 0.13
Effective therapy at any moment 8 (11.9) 11 (50) 3 (6.7) 0.001
Effective therapy before CL removal 9 (13.4) 6 (27.3) 2 (4.4) 0.01
Effective therapy at CL removal 9 (13.4) 7 (31.8) 2 (4.4) 0.04
Effective therapy after CL removal 11 (16.4) 9 (40.9) 2 (4.4) 0.53
Duration of catheter in situ 12.35 ± 10.95 9.78 ± 9.17 13.59 ± 11.63 0.23
Poor outcome 45 (67) 4 (80) 41 (66) 1
CL, central line; MRSA, methicillin-resistant S. aureus; MRSA, methicillin-sensitive S. aureus.
Boldface p-values indicate signiﬁcant difference between poor and good outcome.
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20.8; 95% CI 2.0–206.1; p 0.009). Administration of anti-
microbial agents failed to show statistical signiﬁcance for out-
come (p 0.99).
Discussion
Our study suggests that in patients with no clinical suspicion
of sepsis at the time of catheter withdrawal, a catheter colo-
nized with S. aureus does not imply a high risk of subsequent
bacteraemia or poor outcome and should not induce sys-
tematically the initiation of antimicrobial therapy.
Staphylococcus aureus bloodstream infection is a severe
infection with a high risk of haematogenous seeding and
endocarditis, and is frequently originated in an infected cath-
eter. In the absence of proven bacteraemia, the interpreta-
tion of catheter colonization by S. aureus has important
implications for the patient and for healthcare costs [7].
According to recent guidelines, catheters should not be sent
for culture if sepsis is not suspected [1]. However, the real-
ity in most hospitals is that two-thirds of positive catheter
tips belong to patients with no concomitant bacteraemia and
that culturing most catheter tips is a common practice.
Other studies evaluating patients with catheter tips colo-
nized by S. aureus had populations that differed widely from
ours (Table 5). Patients were frequently in severe clinical
condition with signs of sepsis and many developed bactera-
emia proven by the blood cultures taken at the time of cath-
eter withdrawal [3,4]. Most catheter-related S. aureus
bacteraemias were simultaneous to the catheter tip culture
(99% in Park’s study [8], 97% in Ruhe’s [4] and 86% in Ekke-
lenkamp’s study [3]). Obviously in these patients early anti-
microbial therapy is advised.
Our objective was to analyse the effect of antimicrobial
therapy in patients with colonized catheters and no clinical
suspicion of sepsis at catheter withdrawal in the opinion of
the attending physician. For that purpose, we selected
patients in whom no blood cultures were even requested
within 7 days of catheter removal and we did not ﬁnd any
signiﬁcant impact of antimicrobial therapy on this popula-
tion’s outcome. Only one patient developed S. aureus bacter-
aemia on day 8 after catheter removal. When we reviewed
the medical records of this patient, we concluded that, in
our opinion, blood cultures should have been obtained ear-
lier because of the presence of signs compatible with cathe-
ter exit site infection.
Park et al. [8] recently showed that bloodstream infection
was rare subsequent to the removal of colonized central
venous catheters in patients with negative concomitant blood
cultures. In his study, most patients with catheter-related T
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S. aureus bacteraemia had positive blood cultures before the
tip result was available and only two patients of the 58 with
S. aureus isolated from the central venous catheter tip cul-
ture developed subsequent bacteraemia (3.4%). Interestingly,
one of these two patients was receiving effective antimicro-
bial therapy and the other was not. In this study, appropriate
antibiotic therapy of patients with S. aureus did not have an
impact on outcome.
Zafar et al.[5] studied 74 episodes of S. aureus catheter tip
cultures in patients with no blood cultures obtained (43%)
or with concomitant negative blood cultures (57%). Cathe-
ters were mainly removed because of fever or sepsis
(58.1%). Subsequent bacteraemia developed in four patients
(one treated), all through sources other than the implicated
intravenous catheter. The presence of MSSA (n = 3 MSSA;
n = 1 MRSA) was the only predictor of bacteraemia.
Ruhe and Menon studied 77 patients with no blood cul-
tures taken or with negative concomitant blood cultures
(57%) [4]. Nine patients developed S. aureus bacteraemia a
mean of 4 days after catheter withdrawal (two were trea-
ted). The proportion of patients with signs of sepsis was high
(56%) and 76.6% received empirical therapy. A Charlson
index ‡ 5 and not receiving early therapy predicted a higher
rate of poor outcome in this population.
Finally, Ekkelenkamp et al. [3] analysed 99 patients with
S. aureus in intravenous catheter tip cultures and found that
85 of 99 episodes of bloodstream infection were concomi-
tant with catheter withdrawal but 12 episodes occurred a
median of 3 days afterwards. In this study, antibiotic treat-
ment had a protective effect. However, as previously men-
tioned, Ekkelenkamp et al. did not specify how many patients
had blood cultures drawn at the same time as the catheter
withdrawal. It is also interesting to underline that the two
patients who died as the result of S. aureus bacteraemia had
fulminant courses and died 2 and 3 days after catheter with-
drawal, so the result of the catheter culture would probably
not be available at that time. Those two patients had signs of
exit site infection but received no empirical therapy.
Our study is limited by its retrospective nature and, as for
the previously mentioned studies, by the relatively small
sample size. However, our cases represent all episodes with
this situation during a 6-year period in a large teaching insti-
tution. As in the previously mentioned studies, molecular
typing of S. aureus strains was not performed.
Our data conﬁrm that patients with intravenous catheters
colonized with S. aureus should be closely monitored for
signs and symptoms of ongoing infection, but if not present,
antimicrobial therapy does not seem justiﬁed. A large
prospective study is needed to identify risk factors for
subsequent S. aureus complications and to avoid unnecessary
use of antimicrobials.
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